Global Cord Blood Corporation
CO was delisted on the 23rd of September, 2022.
25 hedge funds and large institutions have $34.7M invested in Global Cord Blood Corporation in 2022 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 9 closing their positions.
552% more call options, than puts
Call options by funds: $352K | Put options by funds: $54K
20% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 5
14% less funds holding
Funds holding: 29 → 25 (-4)
18% less capital invested
Capital invested by funds: $42.5M → $34.7M (-$7.84M)
33% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OMC
Oasis Management Company
Grand Cayman,
Cayman Islands
|
+$3.82M |
| 2 |
FCM
FourWorld Capital Management
New York
|
+$353K |
| 3 |
Morgan Stanley
New York
|
+$250K |
| 4 |
BFM
Boothbay Fund Management
New York
|
+$141K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$101K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Man Group
London,
United Kingdom
|
-$5.58M |
| 2 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$1.73M |
| 3 |
Renaissance Technologies
New York
|
-$446K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$140K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$135K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
Qube Research & Technologies (QRT)
London,
United Kingdom
| – | -$1.73M | -448,755 | Closed |
|
|
27
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$135K | -43,547 | Closed |
|
|
DCM
28
DGS Capital Management
Jersey City,
New Jersey
| – | -$121K | -31,516 | Closed |
|
|
CCIA
29
Campbell & Co Investment Adviser
Baltimore,
Maryland
| – | -$56K | -14,500 | Closed |
|
|
BRWA
30
B. Riley Wealth Advisors
Boca Raton,
Florida
| – | -$39K | -10,050 | Closed |
|
31
Fidelity Investments
Boston,
Massachusetts
| – | -$4K | -926 | Closed |
|
|
TRCT
32
Tower Research Capital (TRC)
New York
| – | -$2K | -457 | Closed |
|
33
JP Morgan Chase
New York
| – | -$2K | -412 | Closed |
|
CO Hedge Fund Activity: Q2 2022 in Review
25 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Global Cord Blood Corporation (CO) for Q2 2022, worth a combined $34.7M — down 18% from $42.5M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of CO and 6 opened new positions — a net loss of 3 holders — while 5 trimmed existing stakes and 6 added.
The largest buyer was Oasis Management Company, adding an estimated $3.82M. The largest seller was Man Group, exiting entirely with an estimated $5.58M sold.
- 25 institutional investors held Global Cord Blood Corporation (CO) as of Q2 2022, down from 29 in Q1 2022.
- Funds reported $34.7M of Global Cord Blood Corporation stock for Q2 2022, down 18% quarter-over-quarter.
- 6 funds opened new Global Cord Blood Corporation positions in Q2 2022 and 9 closed out, a net change of -3 holders.
- The largest Global Cord Blood Corporation buyer in Q2 2022 was Oasis Management Company, an estimated $3.82M added.
- The largest Global Cord Blood Corporation seller in Q2 2022 was Man Group, an estimated $5.58M sold.
Based on aggregated 13F filings for Q2 2022.